New Approach Methodologies (NAMs) Market
完整報告名稱與涵蓋範圍
New Approach Methodologies (NAMs) Market Size, Share & Trends Analysis Report, By Technology (Organ-on-a-Chip and Microphysiological Systems, 3D Cell Culture, Organoids and Tissue Models, In Silico Modelling, Quantitative Systems Pharmacology and AI Toxicology, In Vitro Assays, High-Content Screening and Omics-Based Methods), By Offering (Platforms, Instruments and Consumables, Software and Modelling Services, Contract Research and Testing Services), By Application (Drug Discovery and Safety Assessment, Regulatory Toxicology and Chemical Safety, Disease Modelling and Efficacy Testing, Personalized Medicine and Clinical Trial Support), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The new approach methodologies market covers organ-on-a-chip and microphysiological systems, three-dimensional cell culture and organoid models, in silico modelling and AI toxicology and advanced in vitro and omics-based assays, together with the platforms, software and contract services that deliver them, used to replace or reduce animal testing in drug discovery, safety assessment, regulatory toxicology and disease modelling. Conventional two-dimensional cell culture, animal research models and general laboratory instruments are excluded.
Momentum has shifted decisively with legislation that removed the animal testing mandate for new drug applications in the United States, regulatory roadmaps to phase out animal requirements for monoclonal antibodies and other products and chemical safety frameworks in Europe that prioritise non-animal methods. Pharmaceutical companies are investing in human-relevant models that better predict liver, cardiac and immune toxicity, in organoid platforms derived from patient tissue and in computational models that integrate in vitro data, while contract research organisations build service offerings and regulators publish qualification pathways. Standardisation, reproducibility, throughput, cost and the evidence required for regulatory acceptance determine the pace at which these methods displace animal studies.
North America and Europe lead adoption and regulatory development, with Japan, South Korea, China and Singapore investing in domestic platforms and standards. Competition involves microphysiological system pioneers, three-dimensional culture and organoid suppliers, modelling software companies, life science tool groups and contract research organisations.
The InsightAce study provides US$ revenue forecasts for every technology, offering, application and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global New Approach Methodologies (NAMs) Market Snapshot
Chapter 4. Global New Approach Methodologies (NAMs) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Technology Estimates & Trend Analysis
5.1. Technology & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Technology:
5.2.1. Organ-on-a-Chip and Microphysiological Systems
5.2.2. 3D Cell Culture, Organoids and Tissue Models
5.2.3. In Silico Modelling, Quantitative Systems Pharmacology and AI Toxicology
5.2.4. In Vitro Assays, High-Content Screening and Omics-Based Methods
Chapter 6. Market Segmentation 2: By Offering Estimates & Trend Analysis
6.1. Offering & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Offering:
6.2.1. Platforms, Instruments and Consumables
6.2.2. Software and Modelling Services
6.2.3. Contract Research and Testing Services
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Drug Discovery and Safety Assessment
7.2.2. Regulatory Toxicology and Chemical Safety
7.2.3. Disease Modelling and Efficacy Testing
7.2.4. Personalized Medicine and Clinical Trial Support
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Contract Research Organizations
8.2.3. Chemical, Cosmetic and Consumer Product Companies
8.2.4. Academic, Government and Regulatory Institutions
Chapter 9. New Approach Methodologies (NAMs) Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Emulate, Inc.
11.2. CN Bio Innovations Ltd.
11.3. MIMETAS B.V.
11.4. InSphero AG
11.5. TissUse GmbH
11.6. Certara, Inc.
11.7. Simulations Plus, Inc.
11.8. Charles River Laboratories International, Inc.
11.9. Corning Incorporated
11.10. Thermo Fisher Scientific Inc.
11.11. Molecular Devices (Danaher)
11.12. Labcorp Drug Development
11.13. Xcellbio
11.14. Vivodyne, Inc.
11.15. Hesperos, Inc.
圖表清單 List of Tables & Figures
Table 1. Global New Approach Methodologies (NAMs) Market Revenue Forecast by Technology, 2026-2035 (US$ Mn)
Figure 1. Global New Approach Methodologies (NAMs) Market Segmentation and Scope Overview
Table 2. Global New Approach Methodologies (NAMs) Market Revenue Forecast by Offering, 2026-2035 (US$ Mn)
Figure 2. Global New Approach Methodologies (NAMs) Market Share by Technology, 2026 & 2035
Table 3. Global New Approach Methodologies (NAMs) Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. New Approach Methodology Landscape from Microphysiological Systems to In Silico Toxicology
Table 4. Global New Approach Methodologies (NAMs) Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Regulatory Milestones Enabling Non-Animal Methods in Drug and Chemical Safety Assessment
Table 5. Global New Approach Methodologies (NAMs) Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific New Approach Methodologies (NAMs) Growth Opportunity Analysis
Table 6. North America New Approach Methodologies (NAMs) Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key New Approach Methodologies (NAMs) Market Participants
Table 7. Europe New Approach Methodologies (NAMs) Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global New Approach Methodologies (NAMs) Market
Table 8. Asia Pacific New Approach Methodologies (NAMs) Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Adoption Pathway for NAMs Across Discovery, Safety and Regulatory Submission Stages, 2026-2035
Table 9. Strategic Developments of Leading New Approach Methodologies (NAMs) Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們